dc.contributor.author | Gallagher, C. T. | |
dc.contributor.author | Greenland, Victoria A. M. | |
dc.contributor.author | Hickman, Adrienne C. | |
dc.date.accessioned | 2015-04-23T14:34:01Z | |
dc.date.available | 2015-04-23T14:34:01Z | |
dc.date.issued | 2015-06 | |
dc.identifier.citation | Gallagher , C T , Greenland , V A M & Hickman , A C 2015 , ' Eram, ergo sum? A 1-year retrospective study of General Pharmaceutical Council fitness to practise hearings ' , International Journal of Pharmacy Practice (IJPP) , vol. 23 , no. 3 , pp. 205-211 . https://doi.org/10.1111/ijpp.12151 | |
dc.identifier.issn | 0961-7671 | |
dc.identifier.other | ORCID: /0000-0002-2107-4522/work/141599672 | |
dc.identifier.uri | http://hdl.handle.net/2299/15821 | |
dc.description | Date of acceptance: 20/08/2014 | |
dc.description.abstract | The principal aims of this research were: to assess whether aggravating and mitigating circumstances considered by the General Pharmaceutical Council (GPhC) when imposing sanctions are considered when determining impairment of fitness to practise and to determine whether those circumstances described by the GPhC in their Indicative Sanctions Guidance (ISG) as warranting erasure from the Register of Pharmacists lead to that outcome. | en |
dc.language.iso | eng | |
dc.relation.ispartof | International Journal of Pharmacy Practice (IJPP) | |
dc.title | Eram, ergo sum? : A 1-year retrospective study of General Pharmaceutical Council fitness to practise hearings | en |
dc.contributor.institution | School of Life and Medical Sciences | |
dc.contributor.institution | Public Health and Patient Safety Unit | |
dc.contributor.institution | Department of Clinical, Pharmaceutical and Biological Science | |
dc.contributor.institution | Centre for Health Services and Clinical Research | |
dc.description.status | Peer reviewed | |
rioxxterms.versionofrecord | 10.1111/ijpp.12151 | |
rioxxterms.type | Journal Article/Review | |
herts.preservation.rarelyaccessed | true | |